UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

The New England journal of medicine, 2015-10, Vol.373 (14), p.1329-1339

2015

Volltextzugriff (PDF)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2015-09, Vol.386 (9999), p.1137-1146

2015

Volltextzugriff (PDF)

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

The Lancet (British edition), 2017-06, Vol.389 (10086), p.2317-2327

2017

Volltextzugriff (PDF)

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Arthritis research & therapy, 2018-03, Vol.20 (1), p.47-11, Article 47

2018

Volltextzugriff (PDF)

Insights into the pathogenesis of psoriatic arthritis from genetic studies

Seminars in immunopathology, 2021-04, Vol.43 (2), p.221-234

2021

Volltextzugriff (PDF)

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants

Nature communications, 2017-05, Vol.8 (1), p.15382-15382, Article 15382

2017

Volltextzugriff (PDF)

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

The Lancet (British edition), 2013-08, Vol.382 (9894), p.780-789

2013

Volltextzugriff (PDF)

Genomic heterozygosity is associated with a lower risk of osteoarthritis

BMC genomics, 2024-01, Vol.25 (1), p.85-85, Article 85

2024

Volltextzugriff (PDF)

Genetic variability of human angiotensin‐converting enzyme 2 (hACE2) among various ethnic populations

Molecular genetics & genomic medicine, 2020-08, Vol.8 (8), p.e1344-n/a

2020

Volltextzugriff (PDF)

Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV)

Scientific reports, 2020-03, Vol.10 (1), p.4925-4925, Article 4925

2020

Volltextzugriff (PDF)

Public attitudes towards genomic data sharing: results from a provincial online survey in Canada

BMC medical ethics, 2023-10, Vol.24 (1), p.1-81, Article 81

2023

Volltextzugriff (PDF)

Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis

Scientific reports, 2020-12, Vol.10 (1), p.21703-21703, Article 21703

2020

Volltextzugriff (PDF)

Current challenges in the genetics of psoriatic arthritis: a report from the GRAPPA 2009 annual meeting

Journal of rheumatology, 2011-03, Vol.38 (3), p.564-566

Rahman, Proton

2011

Volltextzugriff (PDF)

Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients

Nature communications, 2018-10, Vol.9 (1), p.4178-10, Article 4178

2018

Volltextzugriff (PDF)

Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis

Arthritis research & therapy, 2020-01, Vol.22 (1), p.14-14, Article 14

2020

Volltextzugriff (PDF)

Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes

American journal of human genetics, 2014-08, Vol.95 (2), p.162-172

2014

Volltextzugriff (PDF)

Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis

American journal of human genetics, 2012-05, Vol.90 (5), p.796-808

2012

Volltextzugriff (PDF)

Macrophage migration inhibitory factor may play a protective role in osteoarthritis

Arthritis research & therapy, 2021-02, Vol.23 (1), p.59-59, Article 59

2021

Volltextzugriff (PDF)

Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis

Rheumatic diseases clinics of North America, 2015-11, Vol.41 (4), p.623-642

2015

Volltextzugriff (PDF)

S930 Safety of Ustekinumab Across Approved Adult Indications: Pooled Safety Analysis in Crohn’s Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis Through up to 5 Years

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S441-S441

2021

Volltextzugriff (PDF)

Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients

Arthritis research & therapy, 2019-11, Vol.21 (1), p.224-5, Article 224

2019

Volltextzugriff (PDF)

Public interest in unexpected genomic findings: a survey study identifying aspects of sequencing attitudes that influence preferences

Journal of community genetics, 2022-04, Vol.13 (2), p.235-245

2022

Volltextzugriff (PDF)

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

Arthritis research & therapy, 2023-04, Vol.25 (1), p.70-70, Article 70

2023

Volltextzugriff (PDF)

Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials

Arthritis research & therapy, 2024-02, Vol.26 (1), p.49-49, Article 49

2024

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(240)
Life Sciences & Biomedicine
(225)
Humans
(201)
Rheumatology
(154)
Female
(104)
Male
(99)
Adult
(91)
Psoriatic Arthritis
(80)
Middle Aged
(78)
Psoriasis
(71)
Arthritis
(59)
Biological And Medical Sciences
(57)
Medical Sciences
(55)
Genetic Predisposition To Disease
(50)
Treatment Outcome
(50)
Arthritis, Psoriatic - Drug Therapy
(46)
Severity Of Illness Index
(43)
Monoclonal Antibodies
(39)
Patients
(38)
Arthritis, Psoriatic - Genetics
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Insights into the pathogenesis of psoriatic arthritis from genetic studies

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

Genomic heterozygosity is associated with a lower risk of osteoarthritis

Genetic variability of human angiotensin‐converting enzyme 2 (hACE2) among various ethnic populations

Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV)

Public attitudes towards genomic data sharing: results from a provincial online survey in Canada

Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis

Current challenges in the genetics of psoriatic arthritis: a report from the GRAPPA 2009 annual meeting

Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases

Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients

Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis

Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes

Rare and Common Variants in CARD14, Encoding an Epidermal Regulator of NF-kappaB, in Psoriasis

Macrophage migration inhibitory factor may play a protective role in osteoarthritis

Genetic, Epigenetic and Pharmacogenetic Aspects of Psoriasis and Psoriatic Arthritis

S930 Safety of Ustekinumab Across Approved Adult Indications: Pooled Safety Analysis in Crohn’s Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis Through up to 5 Years

Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients

Public interest in unexpected genomic findings: a survey study identifying aspects of sequencing attitudes that influence preferences

Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials

Suchergebnisse filtern